⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2906570 | 1.00 | — | — | |
| SCHEMBL3133180 | 1.00 | — | — | |
| SCHEMBL366631 | 0.75 | ALDH1A1 (0.45) | — | |
| SCHEMBL3134095 | 0.74 | HSD11B1 (0.44) | — | |
| SCHEMBL3134885 | 0.74 | HSD11B1 (0.44) | — | |
| SCHEMBL208699 | 0.74 | HSD11B1 (0.44) | — | |
| Ammonia Solution, Strong SCHEMBL9795266 | 0.73 | ALDH1A1 (0.43) | — | |
| SCHEMBL28470848 | 0.72 | NFE2L2 (0.60) | — | |
| SCHEMBL3126254 | 0.72 | HSD17B10 (0.46) | — | |
| SCHEMBL206780 | 0.72 | CYP2A6 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180243298-A1 | TRPV3 MODULATORS | ABBVIE INC. | 2018-08-30 | — | — | US | claimed |
| WO-2016160938-A1 | N-(1,3-THIAZOL-2-YL)PYRIMIDINE-5-CARBOXAMIDES AS TRPV3 MODULATORS | ABBVIE INC. (US) | 2016-10-06 | — | — | WO | claimed |
| EP-2183213-A2 | OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME | Kyung Nong Corporation (KR) | 2010-05-12 | — | — | EP | claimed |
| WO-2009005297-A2 | OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2009-01-08 | — | — | WO | claimed |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION | 2007-04-05 | — | — | US | claimed |
| EP-1144403-B1 | SUBSTITUTED PYRAZOLES AS P38 KINASE INHIBITORS | SEARLE LLC (US) | 2004-10-06 | — | — | EP | claimed |
| US-20040176433-A1 | treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis | PHARMACIA CORPORATION | 2004-09-09 | — | — | US | claimed |
| US-6617324-B1 | Phenyl, cyclohexyl and pyridinyl or pyrimidinyl-substituted | G. D. SEARLE & COMPANY | 2003-09-09 | — | — | US | claimed |
| US-6514977-B1 | For treating p38 kinase mediated disorders | G.D. SEARLE & COMPANY | 2003-02-04 | — | — | US | claimed |
| US-6423713-B1 | Substituted pyrazoles as p38 kinase inhibitors | G. D. SEARLE & COMPANY | 2002-07-23 | — | — | US | claimed |
| EP-1144403-A1 | SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000031063-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-06-02 | — | — | WO | claimed |
| EP-1000055-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. Searle & Co. (US) | 2000-05-17 | — | — | EP | claimed |
| WO-1998052940-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE AND CO. (US) | 1998-11-26 | — | — | WO | claimed |
| CN-117083309-A | Photocurable composition and pattern forming method | 东京应化工业株式会社 | 2023-11-17 | — | — | CN | disclosed |
| CN-117024333-A | Oxime ether compound containing styryl and preparation method and application thereof | 贵州大学 | 2023-11-10 | — | — | CN | disclosed |
| CN-116981700-A | Photocurable composition and pattern forming method | 东京应化工业株式会社 | 2023-10-31 | — | — | CN | disclosed |
| US-5104883-A | Cardiovascular, respiratory, gastrointestirol, urogenital disorders; baldness; premature labor | MAY & BAKER LIMITED (GB) | 1992-04-14 | — | — | US | disclosed |
| EP-0377532-A1 | Thioformamide derivatives | MAY AND BAKER LIMITED (GB) | 1990-07-11 | — | — | EP | disclosed |
| US-4269990-A | CHEMICAL INTERMEDIATES FOR 1-UNSUBSTITUTED-2-(4-INDANYL- OR 5-NAPHTHYLAMINO)-2-IMIDAZOLINE, USEFUL AS DRUGS | BASF AKTIENGESELLSCHAFT (DE) | 1981-05-26 | — | — | US | disclosed |